Skip to main content
Fig. 1 | Clinical Epigenetics

Fig. 1

From: Targeted demethylation of the SLC5A7 promotor inhibits colorectal cancer progression

Fig. 1

SLC5A7 downregulation is modulated by DNA methylation in CRC. A SLC5A7 mRNA expression levels in HCT116 and RKO after DAC and AZA treatment (**p < 0.01, compared with the DMSO group). B SLC5A7 protein expression levels in HCT116 and RKO after DAC and AZA treatment, GAPDH was used as a loading control. C SLC5A7 mRNA expression levels in HCT116 and RKO after transfection of siNC, siDNMT1, siDNMT3a, siDNMT3b (p < 0.01, compared with the siNC group). D SLC5A7 protein expression levels in HCT116 and RKO after transfection of siNC, siDNMT1, siDNMT3a, siDNMT3b, GAPDH was used as a loading control

Back to article page